-transparent.png){kind=logo}
Kawasaki disease (KD, or acute febrile mucocutaneous lymph node syndrome (MCLS)) was first described as a clinical entity in 1967 by Dr. Tomisaku Kawasaki of the Japan Red Cross Medical Center. Originally, it was thought to have a favorable prognosis, but as epidemiological surveys, augmented by pathological studies, have shown, it has come to be recognized as an often fatal disorder. In this report, the clinical symptoms, historical background, present status of research and epidemiological problems of KD are first described, and then we present a pathological and morphological outline of KD, focusing on pathological changes in the blood vessels, and the relationships of these changes to 1) the morphogenesis of arteritis, 2) the mechanism of coronary artery aneurysm formation and its sequelae, and 3) juvenile arteriosclerosis.
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
July 2013,
Head and neck pathology,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
January 1969,
Israel journal of medical sciences,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
May 1998,
The Australasian journal of dermatology,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
September 2010,
Insights into imaging,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
October 2012,
Zhonghua er ke za zhi = Chinese journal of pediatrics,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
January 1987,
Progress in clinical and biological research,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
January 1999,
Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
October 1997,
Journal of gastroenterology and hepatology,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
August 1968,
Australasian annals of medicine,
S Naoe, and
K Takahashi, and
H Masuda, and
N Tanaka
September 1992,
The Science of the total environment,
